A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)
Clinical trial NCT03223376 · COMPLETED
Trial details
- NCT number
- NCT03223376
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-18
- Primary completion
- 2022-09-09
- Enrollment
- 703
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.